Abstract LB-213: Plasma soluble VEGFR1 is a potential dual biomarker of response and toxicity for bevacizumab with chemoradiation in locally advanced rectal cancer

Published

Journal Article

Full Text

Duke Authors

Cited Authors

  • Duda, DG; Willett, CG; Ancukiewicz, M; di Tomaso, E; Shah, M; Czito, BG; Bentley, R; Poleski, M; Lauwers, GY; Carroll, M; Tyler, D; Mantyh, C; Shellito, P; Clark, JW; Jain, RK

Published Date

  • April 15, 2010

Published In

  • Clinical Research

Published By

Digital Object Identifier (DOI)

  • 10.1158/1538-7445.am10-lb-213